Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder

Inclusion Criteria:

1. Ability and willingness to provide written informed consent.

2. Male and female subjects aged 18-65 years, inclusive.

3. Current diagnosis of social anxiety disorder.

4. Liebowitz Social Anxiety Scale total score ≥60.

5. Public Speaking Anxiety Scale total score ≥60.

6. Hamilton Depression Rating Scale score ≤18.

Exclusion Criteria:

1. Suicide attempts and/or suicidal ideation in the past 2 years or currently at riskof suicide in the opinion of the investigator.

2. History of bipolar disorder, schizophrenia, psychosis, seizures, delusionaldisorders, obsessive-compulsive disorder, or autism spectrum disorder.

3. Posttraumatic stress disorder or an eating disorder in the past 6 months.

4. Substance or alcohol use disorder in the past 6 months or positive in drug/alcoholscreening.

5. Psychotherapy in the past 6 months.

6. Psychotropic medication in the past 2 months.

7. Current or planned pregnancy or nursing during the trial period.

8. Any other reason as determined by the Investigator which may lead to an unfavorablerisk-benefit of study participation, or interference with study objectives.